Targeted interventions could help reduce pre-test anxiety, improve the physical screening experience, and address structural barriers in underserved settings.
Pitting three multipurpose LLMs against two healthcare-specific AI tools, researchers have discovered the consumer-level AI can beat its purpose-built counterparts in healthcare scenarios—and soundly, at that.
The lawsuit dates back to 2019 but has been stuck in the court process for years. In the end, the health plan will pay Pomona Valley Hospital for emergency care delivered to patients at an out-of-network rate—though the facility didn’t get all of what it was seeking.
State Attorney General James Uthmeier is forcing the company to hand over thousands of documents related to its pharmacy contracts and reimbursement policies to see if the retail giant is abusing its position in the market as both a pharmacy benefit manager and a retail chain of drug stores.
Researchers believe the technique also could have utility for brain, head and neck MRI applications and could eventually be adapted to other imaging modalities as well.
“Given recent Centers for Medicare and Medicaid Services coverage of CTC for CRC screening, this study and its conclusions are more important than ever,” experts write.
Andover, Mass.-based Commonwealth Radiology Associates is teaming with Heywood Healthcare, an independent, community-owned hospital group, to deliver imaging services.
Founded in 2018, Positrigo scored U.S. Food and Drug Administration clearance last year for its NeuroLF brain PET system, which is targeted toward Alzheimer's.
On the technical and ethical planes, the National Academy of Medicine’s fresh guidance may represent the best way yet to ensure alignment of healthcare AI stakeholders.
Targeted interventions could help reduce pre-test anxiety, improve the physical screening experience, and address structural barriers in underserved settings.
